DRAINAD Trademark

Trademark Overview


On Friday, September 30, 2016, a trademark application was filed for DRAINAD with the United States Patent and Trademark Office. The USPTO has given the DRAINAD trademark a serial number of 79206144. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 13, 2024. This trademark is owned by Immungenetics AG. The DRAINAD trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in neurodegenerative diseases; biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in dementia disorders and their earlier stages, in particular for use in Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for prevention against neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing dementia disorders and their earlier stages, in particular for preventing Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatme...

Chemical products for the production of viral, retroviral and non-viral vectors
drainad

General Information


Serial Number79206144
Word MarkDRAINAD
Filing DateFriday, September 30, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 13, 2024
Registration Number5409575
Registration DateTuesday, February 27, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements


Goods and ServicesBiochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in neurodegenerative diseases; biochemical and chemical preparations for medical purposes in particular those with the active ingredient thiethylperazine, for use in dementia disorders and their earlier stages, in particular for use in Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for prevention against neurodegenerative diseases; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for preventing dementia disorders and their earlier stages, in particular for preventing Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration forms, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in oral administration form, namely, pills, tablets, dragées, capsules, liquids, drops, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes, in particular those with the active ingredient thiethylperazine, for the treatment of dementia disorders and their earlier stages, in particular for the treatment of Alzheimer's disease and mild cognitive impairment; biochemical and chemical preparations for medical purposes in parenteral administration form, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of neurodegenerative diseases; biochemical and chemical preparations for medical purposes in parenteral administration forms, namely, injection solutions and infusion solutions, in particular including as active ingredient thiethylperazine, for the prevention and/or treatment of Alzheimer's disease and mild cognitive impairment
Pseudo MarkDRAIN AD
Goods and ServicesChemical products for the production of viral, retroviral and non-viral vectors

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 13, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 13, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmungenetics AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressDE

Party NameImmungenetics AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressDE

Party NameImmungenetics AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Saturday, May 6, 2017APPLICATION FILING RECEIPT MAILED
Friday, September 29, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 27, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, May 2, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 2, 2017ASSIGNED TO EXAMINER
Tuesday, May 9, 2017NON-FINAL ACTION WRITTEN
Wednesday, May 10, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 18, 2017REFUSAL PROCESSED BY MPU
Thursday, May 18, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 3, 2017REFUSAL PROCESSED BY IB
Wednesday, November 22, 2017NOTICE OF PUBLICATION
Wednesday, November 22, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 22, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 21, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 12, 2017ASSIGNED TO LIE
Friday, October 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 20, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 8, 2017NOTIFICATION PROCESSED BY IB
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER
Sunday, May 27, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, June 4, 2018FINAL DISPOSITION PROCESSED
Friday, June 29, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 4, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 26, 2019NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, October 20, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 11, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, February 27, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, September 13, 2024CANCELLED SECTION 71